Evidence map›Paper›PMID 41060700›Full record

ArticleACS nano2025

Modular Virus Capsid Coatings for Biocatalytic DNA Origami Nanoreactors.

Iris Seitz, Donna McNeale, Frank Sainsbury, Veikko Linko, Mauri A Kostiainen

Abstract read
In one paragraph

Article in ACS nano, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. DNA Nanostructures for siRNA Delivery.Bioconjugate chemistry · 2026
    Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Iris SeitzDepartment of Bioproducts and Biosystems, Aalto University, Aalto 00076, Finland.
Donna McNealeDepartment of Bioproducts and Biosystems, Aalto University, Aalto 00076, Finland.
Frank SainsburyCentre for Cell Factories and Biopolymers, Institute for Biomedicine and Glycomics, Griffith University, Nathan, Brisbane, QLD 4111, Australia.ORCID 0000-0001-8152-3820
Veikko LinkoDepartment of Bioproducts and Biosystems, Aalto University, Aalto 00076, Finland.ORCID 0000-0003-2762-1555
Mauri A KostiainenDepartment of Bioproducts and Biosystems, Aalto University, Aalto 00076, Finland.ORCID 0000-0002-8282-2379

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Protein cages and custom DNA structures have emerged as self-assembling nanocompartments to sequester enzymes and mimic the compartmentalization of naturally occurring biocatalytic reactions. Protein cages excel in gating the interaction between enzyme and substrate, which can be affected by the physicochemical properties of protein units, whereas the high addressability of DNA origami allows stoichiometric control over the enzyme loading and precise positioning of enzymes. Nevertheless, both approaches would benefit from overcoming the challenges related to controlled enzyme loading and substrate flux, which could be resolved by combining the two nanomaterials. Here, we assemble virus capsid proteins on an enzyme-loaded DNA origami nanoreactor in a modular manner and demonstrate size-selective uptake of substrate molecules depending on the amount and type of capsid protein used for the encapsulation. The capsid cage also protects the biocatalytic unit from degradation, and further functionalization of the reactor surface with an antibody fragment allows targeting for delivery purposes. Thus, our approach provides an attractive platform not only for biomedical applications but also, because of its modularity, for rapid investigation of the physicochemical properties of capsid proteins.

Indexed as

CapsidCapsid ProteinsDNANanostructuresNanotechnologyBiocatalysisCapsid ProteinsDNAantigen targetingbiocatalysisDNA origaminanoreactorvirus capsid proteins

Identifiers

PMID41060700
PMCPMC12548342

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.